247 related articles for article (PubMed ID: 17311212)
1. [Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas].
Idoate MA; Echeveste J
Rev Neurol; 2007 Feb 16-28; 44(4):217-24. PubMed ID: 17311212
[TBL] [Abstract][Full Text] [Related]
2. [Towards a molecular classification of gliomas].
Hoang-Xuan K; Idbaih A; Mokhtari K; Sanson M
Bull Cancer; 2005 Apr; 92(4):310-6. PubMed ID: 15888387
[TBL] [Abstract][Full Text] [Related]
3. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
4. Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity.
Walker C; du Plessis DG; Joyce KA; Machell Y; Thomson-Hehir J; Al Haddad SA; Broome JC; Warnke PC
Clin Cancer Res; 2003 Oct; 9(13):4841-51. PubMed ID: 14581356
[TBL] [Abstract][Full Text] [Related]
5. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
6. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
7. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
8. [Histological classification of human gliomas: state of art and controversies].
Figarella-Branger D; Bouvier C
Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
[TBL] [Abstract][Full Text] [Related]
10. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
[TBL] [Abstract][Full Text] [Related]
11. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
Born PW; Broholm H; Laursen H
Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
[TBL] [Abstract][Full Text] [Related]
12. Two types of chromosome 1p losses with opposite significance in gliomas.
Idbaih A; Marie Y; Pierron G; Brennetot C; Hoang-Xuan K; Kujas M; Mokhtari K; Sanson M; Lejeune J; Aurias A; Delattre O; Delattre JY
Ann Neurol; 2005 Sep; 58(3):483-7. PubMed ID: 16130103
[TBL] [Abstract][Full Text] [Related]
13. Molecular subclassification of diffuse gliomas: seeing order in the chaos.
Huse JT; Phillips HS; Brennan CW
Glia; 2011 Aug; 59(8):1190-9. PubMed ID: 21446051
[TBL] [Abstract][Full Text] [Related]
14. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
Gupta M; Djalilvand A; Brat DJ
Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
[TBL] [Abstract][Full Text] [Related]
15. Pathological classification of brain tumors.
Pollo B
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):103-11. PubMed ID: 22617234
[TBL] [Abstract][Full Text] [Related]
16. [Biology of gliomas].
Ducray F
Cancer Radiother; 2008 Nov; 12(6-7):663-8. PubMed ID: 18838326
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M
Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.
Kujas M; Lejeune J; Benouaich-Amiel A; Crinière E; Laigle-Donadey F; Marie Y; Mokhtari K; Polivka M; Bernier M; Chretien F; Couvelard A; Capelle L; Duffau H; Cornu P; Broët P; Thillet J; Carpentier AF; Sanson M; Hoang-Xuan K; Delattre JY
Ann Neurol; 2005 Aug; 58(2):322-6. PubMed ID: 16049942
[TBL] [Abstract][Full Text] [Related]
19. Molecular changes in brain tumors: prognostic and therapeutic impact.
Sanson M; Laigle-Donadey F; Benouaich-Amiel A
Curr Opin Oncol; 2006 Nov; 18(6):623-30. PubMed ID: 16988585
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnostics of gliomas: the clinical perspective.
Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M
Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]